Aarti Drugs Ltd.

View in App
455.40 +18.55 ▲4.3%

01 June 2023, 04:01:00 PM
Volume: 61,841

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.aartidrugs.com
Market Cap 4,217.00 Cr.
Enterprise Value(EV) 4,823.52 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 17.96 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 25.36 Trailing Twelve Months Ending 2023-03
Industry PE 32.05 Trailing Twelve Months Ending 2023-03
Book Value / Share 128.77 Trailing Twelve Months Ending 2023-03
Price to Book Value 3.54 Calculated using Price: 455.40
Dividend Yield 0.22 Period Ending 2022-03
No. of Shares Subscribed 9.26 Cr. 92,600,000 Shares
FaceValue 10
About Aarti Drugs Ltd.
Aarti Drugs (ADL), incorporated in 1984, is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals. The company is part of $265 million Aarti Group of Industries.

Aarti Drugs Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Aarti Drugs Ltd. Performance

View details >>
1 Day
+4.25%
1 Week
+2.16%
1 Month
+8.20%
3 Month
+24.31%
6 Month
+1.41%
1 Year
+3.79%
2 Year
-38.16%
5 Year
+247.47%
10 Year
+1598.62%

Aarti Drugs Ltd. Fundamental Ratios

View details >>
9 years 2011-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 15.18 32.78 20.65 21.60 19.24 17.97 23.65 35.81 21.03
Return on Capital Employed (%) 13.12 23.93 17.95 18.14 17.31 17.01 21.39 34.52 20.75
Return on Assets (%) 4.99 10.13 6.53 7.13 6.38 6.31 9.33 16.78 10.32

Aarti Drugs Ltd. Balance Sheet

View details >>
Particulars 10 years 2011-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 163 308 357 400 455 543 652 913 1,036 1,192
Non Curr. Liab. 290 211 244 297 312 321 301 257 232 296
Curr. Liab. 70 483 501 494 622 591 623 595 940 933
Minority Int. 0 0 0
Equity & Liab. 523 1,002 1,102 1,191 1,389 1,455 1,577 1,766 2,208 2,421
Non Curr. Assets 264 476 537 620 653 671 673 709 815 929
Curr. Assets 260 526 565 571 737 784 904 1,057 1,393 1,492
Misc. Exp. not W/O
Total Assets 523 1,002 1,102 1,191 1,389 1,455 1,577 1,766 2,208 2,421

Aarti Drugs Ltd. Profit and Loss

View details >>
Particulars 10 years 2011-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 501 1,097 1,140 1,195 1,244 1,561 1,806 2,155 2,489 2,716
Other Income 0 1 4 1 2 1 5 11 2
Total Income 501 1,098 1,140 1,199 1,245 1,563 1,808 2,159 2,500 2,718
Total Expenditure -432 -925 -960 -1,005 -1,042 -1,350 -1,541 -1,714 -2,156 -2,410
PBIDT 69 173 180 194 203 213 267 445 344 308
Interest -17 -42 -48 -40 -38 -44 -37 -26 -24 -33
Depreciation -19 -31 -37 -38 -40 -43 -49 -50 -50 -50
Taxation -10 -22 -27 -34 -42 -41 -44 -89 -65 -58
Exceptional Items 4 4 0
PAT 24 77 69 82 82 90 141 280 205 166
Minority Interest 0 0 0
Share Associate 0
Other Related Items
Consolidated Net Profit 24 77 69 82 82 90 141 280 205 166
Adjusted EPS 2 8 7 9 9 10 15 30 22 18

Aarti Drugs Ltd. Cash Flow

View details >>
Particulars 10 years 2010-03 Rs. Cr. 2011-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 59 21 105 133 175 70 143 251 155 70
Cash Fr. Inv. -30 -76 -107 -99 -107 -74 -62 -33 -72 -149
Cash Fr. Finan. -24 53 1 -33 -68 4 -80 -215 -81 92
Net Change 5 -3 -1 1 0 0 1 2 2 13
Cash & Cash Eqvt 9 5 4 5 3 3 5 7 9 22

Aarti Drugs Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 60.20 60.14 60.12 59.99 59.83 59.98 59.77 59.66 59.58
Public 39.80 39.86 39.88 40.01 40.17 40.02 40.23 40.34 40.42
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Aarti Drugs Ltd. Announcements

View details >>
Fri, 26 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the FY ended March 31 2023.
Mon, 22 May 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Wed, 17 May 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for issuance of Letter of Confirmation in lieu of Duplicate Share Certificate

Aarti Drugs Ltd. Technical Scans

View details >>
Thu, 01 Jun 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at Low Opening at Low

Aarti Drugs Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 236,934.33 987.50 +1.1%
Divi's Laboratories Ltd. 93,571.04 3,524.75 +2.1%
Cipla Ltd. 77,836.62 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. 75,790.17 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. 69,284.07 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. 60,079.14 1,775.15 -3.8%
Mankind Pharma Ltd. 56,008.27 1,398.15 +2.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.96 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 51.32 3,524.75 +2.1%
Cipla Ltd. Consolidated 2023-03 27.78 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 16.82 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 84.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.26 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 41.95 1,398.15 +2.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.23 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7.33 3,524.75 +2.1%
Cipla Ltd. Consolidated 2023-03 3.33 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.25 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.19 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.69 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 5.39 1,398.15 +2.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 0.04 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,398.15 +2.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 13.10 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,398.15 +2.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 13.10 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,398.15 +2.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,398.15 +2.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,398.15 +2.9%

Aarti Drugs Ltd. FAQ's

What is Aarti Drugs share price?
Can I buy Aarti Drugs shares now?
What is the Dividend Yield of Aarti Drugs?
What is the Market Cap of Aarti Drugs?
What are the key metrics to analyse Aarti Drugs?
What is the 52 Week High and Low of Aarti Drugs?
What is the trend of Aarti Drugs share price?